Homology Medicines Inc (DELISTED) (FIXX:DL)
0.9347
-15.76
(-94.40%)
USD |
NASDAQ |
Mar 25, 16:00
0.92
-0.01
(-1.57%)
After-Hours: 20:00
Homology Medicines Enterprise Value: -79.63M for March 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| March 25, 2024 | -79.63M |
| March 22, 2024 | -28.73M |
| March 21, 2024 | -31.22M |
| March 20, 2024 | -30.05M |
| March 19, 2024 | -30.32M |
| March 18, 2024 | -30.33M |
| March 15, 2024 | -29.42M |
| March 14, 2024 | -28.75M |
| March 13, 2024 | -29.75M |
| March 12, 2024 | -30.48M |
| March 11, 2024 | -29.76M |
| March 08, 2024 | -30.93M |
| March 07, 2024 | -30.19M |
| March 06, 2024 | -29.79M |
| March 05, 2024 | -31.43M |
| March 04, 2024 | -30.82M |
| March 01, 2024 | -30.73M |
| February 29, 2024 | -29.17M |
| February 28, 2024 | -29.17M |
| February 27, 2024 | -29.46M |
| February 26, 2024 | -30.81M |
| February 23, 2024 | -32.54M |
| February 22, 2024 | -33.19M |
| February 21, 2024 | -32.08M |
| February 20, 2024 | -34.76M |
| Date | Value |
|---|---|
| February 16, 2024 | -36.14M |
| February 15, 2024 | -40.80M |
| February 14, 2024 | -41.67M |
| February 13, 2024 | -41.57M |
| February 12, 2024 | -42.31M |
| February 09, 2024 | -42.21M |
| February 08, 2024 | -41.67M |
| February 07, 2024 | -41.36M |
| February 06, 2024 | -41.59M |
| February 05, 2024 | -41.85M |
| February 02, 2024 | -42.02M |
| February 01, 2024 | -42.05M |
| January 31, 2024 | -43.78M |
| January 30, 2024 | -44.35M |
| January 29, 2024 | -43.31M |
| January 26, 2024 | -42.27M |
| January 25, 2024 | -46.07M |
| January 24, 2024 | -48.25M |
| January 23, 2024 | -48.42M |
| January 22, 2024 | -48.89M |
| January 19, 2024 | -48.68M |
| January 18, 2024 | -49.14M |
| January 17, 2024 | -48.20M |
| January 16, 2024 | -48.99M |
| January 12, 2024 | -48.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-176.36M
Minimum
May 24 2022
732.98M
Maximum
Mar 04 2020
154.59M
Average
146.64M
Median
Enterprise Value Benchmarks
| Societal CDMO Inc (DELISTED) | 145.26M |
| AgeX Therapeutics Inc (DELISTED) | 29.47M |
| NovaBay Pharmaceuticals Inc | 3.382M |
| Palatin Technologies Inc | 19.39M |
| iBio Inc | 30.46M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.12M |
| Total Expenses (Quarterly) | 9.414M |
| EPS Diluted (Quarterly) | -4.86 |
| Earnings Yield | -3.76K% |
| Normalized Earnings Yield | -4429.23 |